Leibniz-Institut für Arterioskleroseforschung (LIFA)
About Leibniz-Institut für Arterioskleroseforschung
The Leibniz Institute for Arteriosclerosis Research (LIFA) has set itself the task of researching the development, prevention and treatment of arteriosclerosis and promoting its prevention and therapy. At LIFA, clinical research into the causes in patients is combined with modern interdisciplinary basic research.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Facts about Leibniz-Institut für Arterioskleroseforschung
Facts about Leibniz-Institut für Arterioskleroseforschung
- Industry : Biotechnology